187 related articles for article (PubMed ID: 19649706)
1. The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer.
Yi C; Mu L; de la Longrais IA; Sochirca O; Arisio R; Yu H; Hoffman AE; Zhu Y; Katsaro D
Breast Cancer Res Treat; 2010 Apr; 120(3):663-9. PubMed ID: 19649706
[TBL] [Abstract][Full Text] [Related]
2. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
Zhu Y; Stevens RG; Leaderer D; Hoffman A; Holford T; Zhang Y; Brown HN; Zheng T
Breast Cancer Res Treat; 2008 Feb; 107(3):421-5. PubMed ID: 17453337
[TBL] [Abstract][Full Text] [Related]
3. Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis.
Yi CH; Zheng T; Leaderer D; Hoffman A; Zhu Y
Cancer Lett; 2009 Nov; 284(2):149-56. PubMed ID: 19457610
[TBL] [Abstract][Full Text] [Related]
4. The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response.
Hoffman AE; Zheng T; Ba Y; Zhu Y
Mol Cancer Res; 2008 Sep; 6(9):1461-8. PubMed ID: 18819933
[TBL] [Abstract][Full Text] [Related]
5. Lack of association of the NPAS2 gene Ala394Thr polymorphism (rs2305160:G>A) with risk of chronic lymphocytic leukemia.
Rana S; Shahid A; Ullah H; Mahmood S
Asian Pac J Cancer Prev; 2014; 15(17):7169-74. PubMed ID: 25227809
[TBL] [Abstract][Full Text] [Related]
6. A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk.
Wang F; Hu Z; Yang R; Tang J; Liu Y; Hemminki K; Sutter C; Wappenschmidt B; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B; Shen H
Breast Cancer Res Treat; 2011 Jun; 127(3):769-75. PubMed ID: 21140207
[TBL] [Abstract][Full Text] [Related]
7. Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.
Zhu Y; Leaderer D; Guss C; Brown HN; Zhang Y; Boyle P; Stevens RG; Hoffman A; Qin Q; Han X; Zheng T
Int J Cancer; 2007 Jan; 120(2):432-5. PubMed ID: 17096334
[TBL] [Abstract][Full Text] [Related]
8. Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer.
Zhou F; He X; Liu H; Zhu Y; Jin T; Chen C; Qu F; Li Y; Bao G; Chen Z; Xing J
Cancer; 2012 Feb; 118(4):937-46. PubMed ID: 21773969
[TBL] [Abstract][Full Text] [Related]
9. Circadian genes and breast cancer susceptibility in rotating shift workers.
Monsees GM; Kraft P; Hankinson SE; Hunter DJ; Schernhammer ES
Int J Cancer; 2012 Dec; 131(11):2547-52. PubMed ID: 22473669
[TBL] [Abstract][Full Text] [Related]
10. Roles of NPAS2 in circadian rhythm and disease.
Peng LU; Bai G; Pang Y
Acta Biochim Biophys Sin (Shanghai); 2021 Oct; 53(10):1257-1265. PubMed ID: 34415290
[TBL] [Abstract][Full Text] [Related]
11. Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients.
Yuan P; Wang S; Zhou F; Wan S; Yang Y; Huang X; Zhang Z; Zhu Y; Zhang H; Xing J
Cancer Sci; 2014 Jul; 105(7):825-32. PubMed ID: 24754267
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants in
He Y; Wang G; Wang Q; Zhao Z; Gan L; Yang S; Wang Y; Guo S; An J; Zhang J; Zhang Z; Zhou F
Future Oncol; 2021 Mar; 17(7):795-805. PubMed ID: 33541123
[No Abstract] [Full Text] [Related]
13. Silencing NPAS2 promotes cell growth and invasion in DLD-1 cells and correlated with poor prognosis of colorectal cancer.
Xue X; Liu F; Han Y; Li P; Yuan B; Wang X; Chen Y; Kuang Y; Zhi Q; Zhao H
Biochem Biophys Res Commun; 2014 Jul; 450(2):1058-62. PubMed ID: 24978311
[TBL] [Abstract][Full Text] [Related]
14. Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells.
Yuan P; Yang T; Mu J; Zhao J; Yang Y; Yan Z; Hou Y; Chen C; Xing J; Zhang H; Li J
Cancer Lett; 2020 Jan; 469():498-509. PubMed ID: 31765736
[TBL] [Abstract][Full Text] [Related]
15. [Expression of circadian gene NPAS2 in colorectal cancer and its prognostic significance].
Yang SF; Xu M; Yang HY; Li PQ; Chi XF
Nan Fang Yi Ke Da Xue Xue Bao; 2016 May; 36(5):714-8. PubMed ID: 27222192
[TBL] [Abstract][Full Text] [Related]
16. High expression of the circadian clock gene NPAS2 is associated with progression and poor prognosis of gastric cancer: A single-center study.
Cao XM; Kang WD; Xia TH; Yuan SB; Guo CA; Wang WJ; Liu HB
World J Gastroenterol; 2023 Jun; 29(23):3645-3657. PubMed ID: 37398880
[TBL] [Abstract][Full Text] [Related]
17. Hylan G-F 20 attenuates posttraumatic osteoarthritis progression: Association with upregulated expression of the circardian gene NPAS2.
Liu CC; Su LJ; Tsai WY; Sun HL; Lee HC; Wong CS
Life Sci; 2015 Nov; 141():20-4. PubMed ID: 26388558
[TBL] [Abstract][Full Text] [Related]
18. Association of CLOCK, ARNTL, and NPAS2 gene polymorphisms and seasonal variations in mood and behavior.
Kim HI; Lee HJ; Cho CH; Kang SG; Yoon HK; Park YM; Lee SH; Moon JH; Song HM; Lee E; Kim L
Chronobiol Int; 2015; 32(6):785-91. PubMed ID: 26134245
[TBL] [Abstract][Full Text] [Related]
19. NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling.
Ma S; Chen Y; Quan P; Zhang J; Han S; Wang G; Qi R; Zhang X; Wang F; Yuan J; Yang X; Jia W; Qin W
BMC Cancer; 2023 Mar; 23(1):280. PubMed ID: 36978001
[TBL] [Abstract][Full Text] [Related]
20. Functional polymorphisms in circadian positive feedback loop genes predict postsurgical prognosis of gastric cancer.
Chen Y; Wang D; Song Y; Zhang X; Jiao Z; Dong J; Lü L; Zou Z; Du W; Qu F
Cancer Med; 2019 Apr; 8(4):1919-1929. PubMed ID: 30843665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
